Literature DB >> 11185492

Influences of different factors on prevalence of ciprofloxacin resistance in Streptococcus pneumoniae in Spain.

C García-Rey, L Aquilar, F Baquero.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11185492      PMCID： PMC90230          DOI： 10.1128/AAC.44.12.3481-3482.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  3 in total

Review 1.  Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Spain: update (1990 to 1996).

Authors:  A Fenoll; I Jado; D Vicioso; A Pérez; J Casal
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

2.  Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: results of a 1-year (1996-1997) multicenter surveillance study. The Spanish Surveillance Group for Respiratory Pathogens.

Authors:  F Baquero; J A García-Rodríguez; J García de Lomas; L Aguilar
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

3.  Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network.

Authors:  D K Chen; A McGeer; J C de Azavedo; D E Low
Journal:  N Engl J Med       Date:  1999-07-22       Impact factor: 91.245
  3 in total
  9 in total

1.  Streptococcus pneumoniae isolates with reduced susceptibility to ciprofloxacin in Spain: clonal diversity and appearance of ciprofloxacin-resistant epidemic clones.

Authors:  L Alou; M Ramirez; C García-Rey; J Prieto; H de Lencastre
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

2.  High genetic diversity of ciprofloxacin-nonsusceptible isolates of Streptococcus pneumoniae in Poland.

Authors:  Ewa Sadowy; Radosław Izdebski; Anna Skoczyńska; Marek Gniadkowski; Waleria Hryniewicz
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

3.  Nonmolecular test for detection of low-level resistance to fluoroquinolones in Streptococcus pneumoniae.

Authors:  Emmanuelle Varon; Serge Houssaye; Sophie Grondin; Laurent Gutmann
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

4.  Trends in antimicrobial resistance in 1,968 invasive Streptococcus pneumoniae strains isolated in Spanish hospitals (2001 to 2003): decreasing penicillin resistance in children's isolates.

Authors:  Jesús Oteo; Edurne Lázaro; Francisco J de Abajo; Fernando Baquero; José Campos
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

5.  Fluoroquinolone resistance in Streptococcus pneumoniae in United States since 1994-1995.

Authors:  Angela B Brueggemann; Stacy L Coffman; Paul Rhomberg; Holly Huynh; Laurel Almer; Angela Nilius; Robert Flamm; Gary V Doern
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

6.  Antimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from 2001 to 2003.

Authors:  Ralf René Reinert; Susanne Reinert; Mark van der Linden; Murat Y Cil; Adnan Al-Lahham; Peter Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

7.  Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain.

Authors:  E Pérez-Trallero; C Fernández-Mazarrasa; C García-Rey; E Bouza; L Aguilar; J García-de-Lomas; F Baquero
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

8.  In vivo efficacy of a new quinolone, DQ-113, against Streptococcus pneumoniae in a mouse model.

Authors:  Yoshiko Otsu; Katsunori Yanagihara; Yuichi Fukuda; Yoshitsugu Miyazaki; Kazuhiro Tsukamoto; Yoichi Hirakata; Kazunori Tomono; Jun-ichi Kadota; Takayoshi Tashiro; Ikuo Murata; Shigeru Kohno
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

9.  Global fluoroquinolone resistance epidemiology and implictions for clinical use.

Authors:  Axel Dalhoff
Journal:  Interdiscip Perspect Infect Dis       Date:  2012-10-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.